Hepatocyte growth factor attenuates collagen accumulation in a murine model of pulmonary fibrosis

Am J Respir Crit Care Med. 2000 Dec;162(6):2302-7. doi: 10.1164/ajrccm.162.6.9908097.


We investigated the in vivo effects of recombinant human hepatocyte growth factor (HGF) on epithelial cell proliferation in normal mouse lung and on the repair process that follows bleomycin-induced lung injury. Intratracheal administration of 100 micrograms of rhHGF to C57BL/6 mice led to proliferation of bronchial and alveolar epithelial cells as indicated by an increased number of cells staining for proliferating cell nuclear antigen (PCNA). The effect of HGF on the lung repair process was examined by administration of 100 micrograms of rhHGF on Day 3 and Day 6 after intratracheal injection of bleomycin to mice. We found that HGF significantly attenuated collagen accumulation induced by bleomycin as determined by quantitation of hydroxyproline content and by scoring of the extent of fibrosis. To explore the potential mechanisms involved in the beneficial effects of HGF, we performed in vitro studies with A549 pulmonary epithelial cells and found that HGF enhanced cell surface plasmin generation, expression of u-PA activity, and cell migration. In summary, HGF has potent in vivo and in vitro effects on epithelial cells, which suggests it may have a role in the therapy of pulmonary fibrosis.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Analysis of Variance
  • Animals
  • Anti-Bacterial Agents
  • Bleomycin
  • Cells, Cultured
  • Collagen / drug effects*
  • Collagen / metabolism
  • Disease Models, Animal*
  • Drug Evaluation, Preclinical
  • Hepatocyte Growth Factor / administration & dosage
  • Hepatocyte Growth Factor / analysis
  • Hepatocyte Growth Factor / pharmacology*
  • Humans
  • Hydroxyproline / analysis
  • Immunohistochemistry
  • Lung / chemistry
  • Lung / drug effects
  • Lung / metabolism
  • Lung / pathology
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Pulmonary Fibrosis / chemically induced
  • Pulmonary Fibrosis / drug therapy*
  • Pulmonary Fibrosis / metabolism
  • Recombinant Proteins / administration & dosage
  • Recombinant Proteins / pharmacology
  • Specific Pathogen-Free Organisms


  • Anti-Bacterial Agents
  • Recombinant Proteins
  • Bleomycin
  • Hepatocyte Growth Factor
  • Collagen
  • Hydroxyproline